Week-32 of gestation (P32) | |||||||||||||||
Amino acid levels (μmol/L) | Control group | n-3 LCPUFA intervention group | P-values regression | ||||||||||||
Con-F (n = 10) | Con-M (n = 9) | N3-F (n = 10) | N3-M (n = 10) | Treatment | Sex | Interaction | Con-M vs Con-F | N3-M vs N3-F | N3-F vs Con-F | N3-M vs Con-M | |||||
Median (25th - 75th) | Median (25th - 75th) | Median (25th - 75th) | Median (25th - 75th) | ||||||||||||
Tau | 98.95 | (76.60–122.08) | 105.70 | (90.75–118.25) | 92.90 | (89.18–103.93) | 78.55 | (70.45–88.95) | 0.027 | 0.425 | 0.285 | 0.830 | 0.191 | 0.376 | 0.023 |
His | 80.70 | (72.05–83.68) | 74.80 | (65.80–76.55) | 76.60 | (72.28–80.85) | 74.70 | (68.93–82.35) | 0.979 | 0.650 | 0.433 | 0.387 | 0.829 | 0.603 | 0.561 |
Val | 155.20 | (140.20–176.68) | 149.10 | (140.45–158.75) | 163.25 | (132.05–179.73) | 156.20 | (131.55–172.65) | 0.696 | 0.697 | 0.683 | 0.576 | 0.983 | 0.985 | 0.575 |
Met | 9.20 | (8.50–10.65) | 9.20 | (7.75–10.65) | 8.90 | (7.73–10.93) | 10.25 | (8.70–11.00) | 0.422 | 0.425 | 0.592 | 0.865 | 0.348 | 0.842 | 0.349 |
Tyr | 31.25 | (29.65–35.98) | 32.80 | (29.60–38.45) | 36.45 | (33.45–39.50) | 32.15 | (29.23–37.08) | 0.189 | 0.803 | 0.508 | 0.521 | 0.755 | 0.166 | 0.687 |
Ile | 42.30 | (32.90–45.23) | 36.70 | (33.55–46.45) | 41.30 | (39.18–45.33) | 38.80 | (34.87–43.65) | 0.965 | 0.546 | 0.918 | 0.726 | 0.618 | 0.919 | 0.968 |
Leu | 71.45 | (66.05–75.33) | 67.10 | (62.60–83.05) | 79.95 | (72.95–82.90) | 73.85 | (63.98–78.45) | 0.269 | 0.558 | 0.640 | 0.929 | 0.461 | 0.271 | 0.646 |
Phe | 37.25 | (34.65–38.95) | 38.10 | (33.15–39.05) | 39.60 | (38.58–42.08) | 38.45 | (35.20–40.85) | 0.063 | 0.556 | 0.428 | 0.912 | 0.329 | 0.065 | 0.459 |
Trp | 35.05 | (32.78–39.05) | 37.40 | (35.05–42.35) | 42.70 | (40.60–45.28) | 39.85 | (34.05–44.53) | 0.004 | 0.613 | 0.225 | 0.225 | 0.596 | 0.004 | 0.217 |
Week-15 of gestation (P15 = baseline) | |||||||||||||||
Amino acid levels (μmol/L) | Control group | n-3 LCPUFA intervention group | P-values regression | ||||||||||||
Con-F (n = 11) | Con-M (n = 9) | N3-F (n = 10) | N3-M (n = 11) | Sex | |||||||||||
Median (25th - 75th) | Median (25th - 75th) | Median (25th - 75th) | Median (25th - 75th) | ||||||||||||
Tau | 106.50 | (67.60–131.10) | 110.60 | (103.60–142.85) | 108.40 | (66.45–131.03) | 108.70 | (92.20–142.30) | 0.175 | ||||||
His | 68.80 | (64.60–76.60) | 69.30 | (61.45–73.40) | 70.95 | (63.68–75.88) | 62.50 | (59.90–66.70) | 0.059 | ||||||
Val | 168.30 | (157.20–191.60) | 172.40 | (146.00–185.05) | 184.55 | (159.20–208.55) | 160.30 | (145.00–178.50) | 0.061 | ||||||
Met | 8.70 | (8.00–11.60) | 9.20 | (8.20–10.10) | 9.80 | (8.83–11.95) | 10.00 | (9.50–10.10) | 0.612 | ||||||
Tyr | 33.30 | (29.40–37.70) | 36.50 | (32.75–40.85) | 36.10 | (31.38–41.83) | 30.20 | (27.20–34.60) | 0.178 | ||||||
Ile | 38.50 | (37.30–42.90) | 38.70 | (37.65–40.50) | 43.25 | (37.88–49.55) | 40.70 | (37.40–45.30) | 0.260 | ||||||
Leu | 80.40 | (76.90–84.20) | 80.40 | (70.60–86.30) | 86.20 | (77.55–92.45) | 81.20 | (72.00–91.10) | 0.234 | ||||||
Phe | 39.00 | (36.70–43.90) | 39.20 | (36.70–41.10) | 40.70 | (38.28–46.65) | 37.40 | (36.30–40.40) | 0.051 | ||||||
Trp | 41.30 | (39.20–46.30) | 44.00 | (40.70–50.40) | 45.40 | (42.35–51.38) | 42.00 | (36.10–47.40) | 0.274 |